Lab rats – how the UK life sciences sector is struggling to seek out house to work


Share Button

The UK wants to build on its already successful position as a globally important player in the life sciences and pharma sectors. Yet it is struggling to create enough space for growth in the right places and having to rethink wher research and innovation takes place In November 2023, plans to show a part of a golf course subsequent to a motorway right into a £340 million science park had been refused by South Oxfordshire District Council. Though now categorized as greenbelt, the situation was the location of a landfill as just lately because the Nineties and is only a stone’s throw from each the A40 trunk highway and M40 motorway. The builders are anticipated to enchantment. Regardless of the particulars of this story, it’s an instance of how difficult it may be to satisfy demand for lab and life sciences house within the so-called Golden Triangle of London, Oxford and Cambridge within the South of England. This lack of provide is appearing as a brake on the UK Authorities’s dream of constructing the nation a “science superpower”.

In keeping with a report earlier this yr from property analyst Bidwells, there may be just about no house left in Oxford or Cambridge for all times science companies to maneuver into. It estimated there may be simply 10,000 sq ft of house accessible in Cambridge, in contrast with two million sq ft of demand. In Oxford, there may be about 25,000 sq ft accessible in contrast with demand for 845,000 sq ft.

This deadlock triggered Dame Emma Walmsley, chief government of GSK, to warn this yr that the UK risked lacking out on the chance to grow to be an excellent greater participant within the economically important life sciences sector.

It’s hanging how weighted Eire’s export figures are to the life sciences, medical and pharmaceutical industries craved by the UK

Simply how important is obvious when evaluating the UK with Eire. Eire’s adjusted per capita GDP determine often called Gross Nationwide Earnings is round 16 p.c larger than the UK’s and better than that of each Germany and France. (The GNI measure was launched by the Irish Authorities to regulate for the inflated GDP determine attributable to Eire’s place as a tax haven for primarily US companies.)

What’s hanging is how weighted the nation’s export figures are to the life sciences, medical and pharmaceutical industries craved by the UK. In keeping with the Observatory of Financial Complexity, in 2021, Eire exported a complete of $212B, making it the thirtieth largest exporter on this planet.

This determine contains vaccines, blood, antisera, toxins and cultures ($36.5B), packaged medicaments ($32.8B), nitrogen heterocyclic compounds utilized in over half of all FDA permitted medication ($22.4B), built-in circuits ($15.3B), and scented mixtures ($9.37B).

As an example the pull of Eire for these sectors, AstraZeneca introduced in 2021 it had chosen the Republic of Eire for a $360 million manufacturing facility reasonably than Britain due to a “discouraging” tax system.

“We’re at one thing of a tipping level if we don’t make the proper choices now,” stated Emma Walmsley. “We actually do should begin to shut the execution hole and align the technique and the chance to the supply.”

 

The case for optimism

Her phrases are echoed by different giants within the sector. Dean Li, president of Merck’s analysis laboratories, praised the UK’s scientific expertise and experience this yr following the beginning of labor on a brand new £1 billion analysis centre in King’s Cross, with hyperlinks to native Universities and the Francis Crick Institute. However he additionally warned that situations might be significantly better.

“We’re nonetheless very bullish on the invention aspect, however there turns into a cap as to how far you advance your funding primarily based on the broader ecosystem,” he claimed in an interview. “We hope that the UK Authorities and the UK individuals and the UK ecosystem make the suitable investments such that MSD sits there and say: Sure, we had been proper to construct it.”

The UK introduced it had rejoined the Horizon Europe programme in September

In Might of this yr, the Authorities introduced a £650 billion bundle of help for the sector. The so-called ‘Life Sci for Development’ contains ten insurance policies reminiscent of £121 million to enhance business scientific trials to deliver new medicines to sufferers quicker, as much as £48 million of latest cash for scientific innovation to organize for any future well being emergencies, £154 million to extend the capability of the UK’s organic knowledge financial institution additional aiding scientific discoveries that assist human well being, and as much as £250 million to incentivise pension schemes to put money into promising science and tech corporations.

It additionally laid out adjustments to planning guidelines to free-up lab house and create a route for the East West Rail line, to enhance connections between Oxford and Cambridge. Sometimes, this plan is now topic to an NAO audit to evaluate its enterprise case.

Encouragingly, the UK additionally introduced it had rejoined the Horizon Europe programme in September, following years of concern concerning the influence of the nation’s withdrawal from the scheme after the Brexit vote in 2016.

Horizon Europe is the most important worldwide analysis collaboration scheme on this planet. In addition to EU members, Norway, Israel and New Zealand are members, with South Korea, Japan and Canada additionally in talks to affix. The joint price range runs to just about €100bn. Beth Thompson of the Wellcome Basis described the transfer as nice information for each researchers and the overall inhabitants.  “Collaboration is nice for the vitality of science within the UK and elsewhere,” she stated. “It’s nice for brand spanking new discoveries and innovation and the economic system. However it’s additionally nice for well being and serving to to resolve the pressing well being challenges the world faces.”

 

An issue of provide and demand

So, in principle, the entire items are in place. The UK has a really wholesome life sciences sector, value round £94 billion a yr and using 300,000 individuals, focussed inevitably on Oxford and Cambridge. It’s estimated that two-thirds of all life sciences startups in Europe are shaped within the UK.

But in each cities builders say the planning system, lack of council sources and native opposition to developments make it unimaginable to place up new amenities to deal with surging demand. In each cities, builders are repurposing defunct retail and workplace amenities in an effort to maintain up with demand.

Even so, Cushman & Wakefield expects the mismatch between provide and demand to persist till at the very least 2025 when 4 million sq ft of lab buildings are attributable to be accomplished.

The availability squeeze has pushed up lab rents to file highs. Earlier than the pandemic, a good laboratory in Cambridge would lease out for about £42 per sq ft, however that is set to exceed £60 per sq ft this yr. Equally, rents for purpose-built labs in Oxford rose 25 per cent in 2022 to £75 per sq ft, a brand new file.

The availability to satisfy rising demand is already growing in different elements of the UK. Canary Wharf is already attempting to reinvent itself as a life sciences hub, because it sees various anchor shoppers within the monetary and authorized providers sector stop for smaller – however not essentially cheaper – workplaces elsewhere in London.

The Qatar Funding Authority and Brookfield, the Canadian investor chaired by Mark Carney, the previous Financial institution of England governor, are investing £400 million in Canary Wharf Group. The organisations, which have owned Canary Wharf Group since 2015, are placing in the identical quantity of capital, that means that they are going to every proceed to personal 50 per cent of Canary Wharf.

The cash will probably be used to fund the plans of Shobi Khan, the chief government of Canary Wharf Group, to reposition the realm as a life sciences and residential hub.

“This funding underscores confidence in our marketing strategy and the strategic repositioning of Canary Wharf,” Khan stated. “Now we have remodeled the property right into a thriving, sustainable mixed-use neighbourhood with award-winning properties, an abundance of facilities and parks, a powerful and distinctive retail supply, and increasing life sciences.”

To draw extra life sciences companies, what the agency refers to as a “WeWork for laboratories” opened this yr and a 22-storey business lab, the most important in Europe, will comply with in 2026.

 

The unfold of innovation

Different cities are getting in on the act. These embrace Aberdeen, with plans championed by Sir Ian Wooden and his Alternative North East developer to put money into analysis and lab amenities in an space finest recognized for its North Sea oil wealth.

We’re at one thing of a tipping level if we don’t make the proper choices now

The Economist reviews that Professor David Blackbourn of the College of Aberdeen says ten firms have been spun out from his establishment. “One, TauRx, primarily based in a former bus depot, is attempting to develop a remedy for Alzheimer’s and has raised over $800m since its founding in 2002. Its innovation, examined in human trials, targets tau tangles (irregular clumps of protein that persist with neurons within the mind). Regulators will quickly decide if that remedy is sufficiently efficient.”

One different level that may encourage life sciences types to maneuver exterior The Golden Triangle is the provision of housing. Planning constraints are additionally evident within the housing markets within the three cities that kind the triangle and they’re incessantly coupled with off-putting excessive rents and home costs. If the UK is severe about its plans to grow to be a world superpower within the subject it might want to consider easy methods to higher develop the sector exterior of the South of England.

All photos: Astra Zeneca’s Cambridge Discovery Centre designed by Hufton+Crow

This text seems in Difficulty 18 of IN Journal

Share this post